Location: Stockholm, Sweden
CIK: 0001599882 · Show all filings
Period: Q4 2014 (← Previous) (Next →)
Filing Date: Feb 9, 2015
Total Value: $345M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Celgene Corp | 182,000 | $20.36M | 5.9% | $113.27 | — | COM | 151020104 |
| GILD | Gilead Sciences Inc | 206,138 | $19.43M | 5.6% | $64.85 | +10.8% | COM | 375558103 |
| CVS | CVS Health Corp | 97,000 | $9.342M | 2.7% | $53.51 | +20.4% | COM | 126650100 |
| REGN | Regeneron Pharmaceuticals Inc | 22,500 | $9.231M | 2.7% | $334.35 | +17.0% | COM | 75886F107 |
| ABBV | AbbVie Inc | 140,000 | $9.162M | 2.7% | $36.22 | +11.1% | COM | 00287Y109 |
| ALKS | Alkermes Plc | 143,000 | $8.374M | 2.4% | $41.72 | +22.1% | COM | G01767105 |
| — | Alexion Pharmaceuticals Inc | 44,000 | $8.141M | 2.4% | $143.60 | — | COM | 015351109 |
| BIIB | Biogen IDEC Inc | 21,500 | $7.298M | 2.1% | $282.74 | +14.4% | COM | 09062X103 |
| — | Medivation Inc | 70,700 | $7.042M | 2.0% | $80.67 | — | COM | 58501N101 |
| — | Actavis Plc | 27,000 | $6.95M | 2.0% | $231.95 | — | COM | G0083B108 |
| BMY | Bristol Myers Squibb Co | 115,000 | $6.788M | 2.0% | $35.05 | +11.0% | COM | 110122108 |
| UTI | Universal Health Services Inc B | 61,000 | $6.787M | 2.0% | $10.52 | 0.0% | COM | 913915104 |
| UNH | United Health Group Inc | 67,000 | $6.773M | 2.0% | $69.66 | +13.8% | COM | 91324P102 |
| — | Receptos Inc | 52,526 | $6.435M | 1.9% | $122.51 | — | COM | 756207106 |
| AMGN | Amgen Inc | 39,168 | $6.239M | 1.8% | $99.35 | +14.0% | COM | 031162100 |
| ESPR | Esperion Therapeutics Inc | 150,000 | $6.066M | 1.8% | $22.47 | +36.2% | COM | 29664W105 |
| — | Rite Aid Corp | 785,000 | $5.903M | 1.7% | $5.17 | — | COM | 767754104 |
| — | Covidien Plc | 57,000 | $5.83M | 1.7% | $84.47 | — | COM | G2554F113 |
| CAH | Cardinal Health Inc | 70,000 | $5.651M | 1.6% | $50.98 | +14.0% | COM | 14149Y108 |
| BMRN | BioMarin Pharmaceutical Inc | 61,000 | $5.514M | 1.6% | $69.41 | +19.8% | COM | 09061G101 |
| ACAD | Acadia Pharmaceuticals Inc | 165,000 | $5.239M | 1.5% | $23.65 | +19.9% | COM | 004225108 |
| ELV | Anthem Inc | 41,000 | $5.152M | 1.5% | $105.54 | 0.0% | COM | 036752103 |
| — | Clovis Oncology Inc | 85,398 | $4.782M | 1.4% | $46.26 | — | COM | 189464100 |
| — | Catamaran Corp | 92,000 | $4.761M | 1.4% | $51.75 | — | COM | 14887102 |
| LLY | Eli Lilly & Co | 66,000 | $4.553M | 1.3% | $48.88 | +12.9% | COM | 532457108 |
| MRK | Merck Co Inc | 80,000 | $4.543M | 1.3% | $32.89 | +19.6% | COM | 58933Y105 |
| VRTX | Vertex Pharmaceuticals Inc | 38,000 | $4.514M | 1.3% | $70.12 | +60.6% | COM | 92532F100 |
| — | Achillion Pharmaceuticals Inc | 368,000 | $4.508M | 1.3% | $9.71 | — | COM | 00448Q201 |
| — | Salix Pharmaceutical Ltd | 38,000 | $4.368M | 1.3% | $102.84 | — | COM | 795435106 |
| — | Celladon Corp | 196,000 | $3.828M | 1.1% | $11.46 | — | COM | 15117E107 |
| — | Nektar Therapeutics | 238,000 | $3.689M | 1.1% | $11.93 | — | COM | 640268108 |
| COR | AmerisourceBergen Corp | 40,000 | $3.606M | 1.0% | $51.53 | +21.9% | COM | 03073E105 |
| DXCM | Dexcom Inc | 64,000 | $3.523M | 1.0% | $8.27 | +47.9% | COM | 252131107 |
| CYH | Community Health Syst Inc | 64,000 | $3.451M | 1.0% | $33.69 | +27.0% | COM | 203668108 |
| — | Intercept Pharmaceuticals Inc | 22,000 | $3.432M | 1.0% | $224.20 | — | COM | 45845P108 |
| MCK | McKesson Corp | 16,000 | $3.321M | 1.0% | $151.16 | +23.6% | COM | 58155Q103 |
| INCY | Incyte Corp Ltd | 44,000 | $3.217M | 0.9% | $48.06 | +35.9% | COM | 45337C102 |
| — | Celldex Therapeutics Inc | 175,000 | $3.194M | 0.9% | $19.03 | — | COM | 15117B103 |
| — | NPS Pharmaceuticals Inc | 89,000 | $3.184M | 0.9% | $27.30 | — | COM | 62936P103 |
| HCA | HCA Holdings Inc | 41,000 | $3.009M | 0.9% | $43.68 | +49.6% | COM | 40412C101 |
| — | Thoratec Corp | 92,000 | $2.986M | 0.9% | $31.71 | — | COM | 885175307 |
| — | Endologix Inc | 194,000 | $2.966M | 0.9% | $14.71 | — | COM | 29266S106 |
| CNC | Centene Corp | 28,000 | $2.908M | 0.8% | $15.09 | +54.7% | COM | 15135B101 |
| JAZZ | Jazz Pharmaceuticals Plc | 17,400 | $2.849M | 0.8% | $158.95 | +4.4% | COM | G50871105 |
| — | Intra-Cellular Therapies Inc | 159,854 | $2.821M | 0.8% | $16.73 | — | COM | 46116X101 |
| — | Cepheid Inc | 52,000 | $2.815M | 0.8% | $47.98 | — | COM | 15670R107 |
| BDX | Becton Dickinson & Co | 20,142 | $2.803M | 0.8% | $107.84 | 0.0% | COM | 075887109 |
| — | Heartware Intl Inc | 38,000 | $2.79M | 0.8% | $73.42 | — | COM | 422368100 |
| — | Abiomed Inc | 73,000 | $2.778M | 0.8% | $26.15 | — | COM | 003654100 |
| TMO | Thermo Fisher Scientific Inc | 22,000 | $2.756M | 0.8% | $106.18 | +10.7% | COM | 883556102 |
| — | Ariad Pharmaceuticals Inc | 397,000 | $2.727M | 0.8% | $6.55 | — | COM | 04033A100 |
| — | Auxilium Pharmaceuticals Inc | 77,000 | $2.648M | 0.8% | $31.74 | — | COM | 05334DAA5 |
| MGNX | Macrogenics Inc | 75,000 | $2.63M | 0.8% | $24.28 | +2.7% | COM | 556099109 |
| — | St Jude Medical Inc | 40,000 | $2.601M | 0.8% | $62.12 | — | COM | 790849103 |
| — | Isis Pharmaceuticals Inc | 42,000 | $2.593M | 0.8% | $36.11 | — | COM | 464330109 |
| — | Array BioPharma Inc | 545,000 | $2.578M | 0.7% | $4.79 | — | COM | 04269X105 |
| — | Amsurg Corp | 47,000 | $2.572M | 0.7% | $47.91 | — | COM | 03232P405 |
| — | Medtronic Inc | 35,000 | $2.527M | 0.7% | $51.32 | — | COM | 585055106 |
| HOLX | Hologic Inc | 94,000 | $2.514M | 0.7% | $23.81 | +8.4% | COM | 436440101 |
| — | Aetna Inc | 28,000 | $2.487M | 0.7% | $81.03 | — | COM | 00817Y108 |
| — | Cerner Corp | 38,000 | $2.457M | 0.7% | $52.57 | — | COM | 156782104 |
| EW | Edwards Lifesciences Corp | 19,000 | $2.42M | 0.7% | $11.54 | +74.1% | COM | 28176E108 |
| PODD | Insulet Corp | 52,000 | $2.395M | 0.7% | $37.55 | +13.9% | COM | 45784P101 |
| — | Tesaro Inc | 62,651 | $2.33M | 0.7% | $31.85 | — | COM | 881569107 |
| ORI | Omnicell Inc | 70,000 | $2.318M | 0.7% | $6.63 | 0.0% | COM | 680223104 |
| — | Orexigen Therapeutics Inc | 375,000 | $2.273M | 0.7% | $5.22 | — | COM | 686164104 |
| — | Tandem Diabetes Care Inc | 179,000 | $2.273M | 0.7% | $12.70 | — | COM | 875372104 |
| — | Pharmacyclics Inc | 18,500 | $2.262M | 0.7% | $103.65 | — | COM | 716933106 |
| ALNY | Alnylam Pharmaceuticals Inc | 23,000 | $2.231M | 0.6% | $76.70 | +20.8% | COM | 02043Q107 |
| — | Cyberonics Inc | 40,000 | $2.227M | 0.6% | $65.00 | — | COM | 23251P102 |
| — | Revance Therapeutics Inc | 126,574 | $2.144M | 0.6% | $27.46 | — | COM | 761330109 |
| SUPN | Supernus Pharmaceuticals Inc | 250,800 | $2.082M | 0.6% | $7.43 | +13.1% | COM | 868459108 |
| LGND | Ligand Pharmaceuticals Inc B | 39,000 | $2.075M | 0.6% | $33.38 | -2.6% | COM | 53220K504 |
| — | Dynavax Technologies Corp | 122,835 | $2.071M | 0.6% | $1.96 | — | COM | 268158102 |
| — | Kite Pharma Inc | 35,000 | $2.018M | 0.6% | $57.66 | — | COM | 49803L109 |
| — | Omnicare Inc | 25,000 | $1.823M | 0.5% | $67.88 | — | COM | 681904108 |
| MYGN | Myriad Genetics Inc | 50,000 | $1.703M | 0.5% | $35.48 | 0.0% | COM | 62855J104 |
| — | Lexicon Pharmaceuticals Inc | 1,594,805 | $1.451M | 0.4% | $1.07 | — | COM | 528872104 |
| — | Keryx Biopharmaceuticals Inc | 90,424 | $1.279M | 0.4% | $12.95 | — | COM | 492515101 |
| — | Mirati Therapeutics Inc | 45,388 | $841K | 0.2% | $18.53 | — | COM | 60449T107 |
| XNCR | Xencor Inc | 50,000 | $802K | 0.2% | $11.60 | 0.0% | COM | 98401F105 |
| — | BIND Therapeutics Inc | 133,535 | $721K | 0.2% | $11.18 | — | COM | 05548N107 |
| — | Threshold Pharmaceuticals | 201,537 | $641K | 0.2% | $4.08 | — | COM | 885807206 |
| — | Anthera Pharmaceuticals Inc | 400,000 | $632K | 0.2% | $2.93 | — | COM | 03674U201 |